ACT2_2D: ACT2, figure 2D

ACT2_2DR Documentation

ACT2, figure 2D

Description

Kaplan-Meier digitized data from ACT2, figure 2D (PMID 26483047). A reported sample size of 233 for a primary endpoint of PFS-3mo in colorectal cancer.

Usage

ACT2_2D

Format

A data frame of 67 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (mut_b, mut_c)

Source

Hagman H, Frödin J-E, Berglund Å, et al. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial. Ann Oncol 2016; 27: 140–7.

Examples

summary(ACT2_2D)

kmplot(ACT2_2D)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.